Skip to content
Digital Focus Europa

Zimbabwe Declines ‘One-Sided’ US Healthcare Assistance Package Due to Information Concerns

Medical aid image
The proposed American funding was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has turned down a major US health deal worth $367m (272 million pounds) spanning five years over Washington's request for confidential data.

This move was revealed following a official document from December was leaked, indicating that President Emmerson Mnangagwa believed the arrangement was "lopsided".

A government representative later explained that the United States was demanding access to genetic material for research and profit while refused to guarantee the resulting advantages from future medical innovations.

"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has urged further talks to secure a agreement acceptable to both sides so the country's critical HIV treatment initiative can proceed.

Wider Background

Zimbabwe's decision follows a comparable case in Kenya, where a court suspended a related deal with the US after legal challenges were filed about the safety of Kenyans' health data.

Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).

The agency had overseen assistance for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.

According to reports, 16 African countries have to date agreed to these new agreements, representing over $18.3bn of fresh investment.

Specifics of the Declined Agreement

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We are confident this cooperation would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via American-funded initiatives," Tremont commented.

However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".

"Zimbabwe was being asked to surrender its biological resources and data indefinitely, without any equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.

"Put simply, our nation would supply the raw materials for medical research without any certainty that the end products would be available to our population should a future health crisis arise."

National Interest and International Frameworks

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending frameworks previously set up through the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.

"This framework is designed to ensure that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."

Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.

"We are open to further discussions with our US partners on how subsequent collaboration could be designed in a manner that respects the sovereignty and dignity of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that negotiations need to persist considering much of the country's HIV programmes were funded by international support.

"Where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group said.

This impasse emphasises the ongoing challenges between receiving much-needed foreign assistance and safeguarding a country's data in an ever more data-driven world.

The writer

Madison Heath

Lena Voss is a seasoned technology journalist with a decade of experience covering digital innovation across Europe.

Digital Focus Europa

Type to search articles.